S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:ACER

Acer Therapeutics News Headlines

$2.20
-0.06 (-2.65%)
(As of 11/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.18
$2.25
50-Day Range
$2.19
$2.90
52-Week Range
$2.15
$5.39
Volume
28,530 shs
Average Volume
557,208 shs
Market Capitalization
$31.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.17

Media Mentions By Week



Acer Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ACER
News Sentiment

0.12

0.26

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ACER Articles
This Week

4

1

ACER Articles
Average Week

Get Acer Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter.

Acer Therapeutics (NASDAQ:ACER) News Headlines Today

SourceHeadline
MarketBeat logoWilliam Blair Comments on Acer Therapeutics Inc.'s FY2021 Earnings (NASDAQ:ACER)
americanbankingnews.com - November 24 at 6:23 AM
MarketBeat logoAcer Therapeutics (NASDAQ:ACER) Posts Quarterly Earnings Results, Beats Estimates By $0.05 EPS
americanbankingnews.com - November 20 at 11:38 AM
markets.businessinsider.com logoEQS-Adhoc: Relief Therapeutics Launches Level 1 ADR Program in the United States
markets.businessinsider.com - November 18 at 1:25 AM
benzinga.com logoRelief Reports that its U.S. Collaboration...
benzinga.com - November 12 at 8:53 AM
MarketBeat logo-$0.28 Earnings Per Share Expected for Acer Therapeutics Inc. (NASDAQ:ACER) This Quarter
americanbankingnews.com - November 11 at 5:20 PM
marketwatch.com logoAcer Therapeutics Gets New Patent for ACER-001 Sodium Phenylbutyrate
marketwatch.com - October 28 at 6:13 AM
msn.com logoBRIEF-Relief Therapeutics And Acer Therapeutics Issue U.S. Patent 11,154,521 Covering ACER-001 Formulation
msn.com - October 26 at 9:55 AM
finance.yahoo.com logoAcer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation
finance.yahoo.com - October 26 at 9:55 AM
uk.finance.yahoo.com logoRelief Therapeutics Reports Two Publications of Positive Data on Nexodyn(R) AOS for Hard-to-Heal Ulcers
uk.finance.yahoo.com - October 20 at 4:32 AM
nasdaq.com logoWhen Will Acer Therapeutics Inc. (NASDAQ:ACER) Turn A Profit?
nasdaq.com - October 11 at 12:47 AM
finance.yahoo.com logoAcer Therapeutics Inc. (NASDAQ:ACER): Are Analysts Optimistic?
finance.yahoo.com - October 9 at 8:54 AM
finance.yahoo.com logoAcer's (ACER) NDA for ACER-001 in UCD Gets FDA Acceptance
finance.yahoo.com - October 7 at 1:52 PM
finance.yahoo.com logoAcer Therapeutics Receives Notice of Allowance of Key U.S. Patent Application Covering ACER-001 Formulation
finance.yahoo.com - October 7 at 8:52 AM
marketwatch.com logoAcer Says FDA Accepts NDA for ACER-001 in Urea-Cycle Disorders; Shares Up
marketwatch.com - October 6 at 1:17 PM
msn.com logoBRIEF-Acer Therapeutics And Relief Therapeutics Announce FDA Acceptance For NDA For Urea Cycle Disorders Treatment
msn.com - October 6 at 1:17 PM
markets.businessinsider.com logoAcer Therapeutics Stock Jumps As UCD Candidate Is Under FDA Review
markets.businessinsider.com - October 6 at 1:17 PM
markets.businessinsider.com logoMid-Day Market Update: Dow Tumbles Over 300 Points; Acer Therapeutics Shares Jump
markets.businessinsider.com - October 6 at 1:17 PM
benzinga.com logoRelief Therapeutics Provides Update on Regulatory...
benzinga.com - September 13 at 4:22 AM
finance.yahoo.com logoAcer Therapeutics to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - August 30 at 9:25 AM
finance.yahoo.com logoOpexa Therapeutics, Inc. (ACER) Reports Q2 Loss, Misses Revenue Estimates
finance.yahoo.com - August 11 at 12:58 AM
finance.yahoo.com logoAcer Therapeutics Reports Q2 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - August 10 at 7:57 PM
msn.com logoBRIEF-Acer Therapeutics And Relief Therapeutics Announce Submission Of A New Drug Application To The U.S. FDA For Acer-001 For Treatment Of Urea Cycle Disorders
msn.com - August 9 at 1:17 PM
finance.yahoo.com logoRELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
finance.yahoo.com - August 9 at 8:16 AM
finanznachrichten.de logoRelief Therapeutics Holding AG: Relief Therapeutics Announces CHF 15 Million Private Placement
finanznachrichten.de - July 27 at 11:36 PM
finance.yahoo.com logoRelief Reports that its U.S. Collaboration Partner has Announced Successful Commercial Formulation for Aviptadil
finance.yahoo.com - July 23 at 5:45 AM
benzinga.com logoRelief Announces Issuance of Shares from Authorized Capital as Approved by 2021 Annual General Meeting
benzinga.com - July 22 at 7:32 AM
nasdaq.com logoAcer Therapeutics Inc. Common Stock (DE) (ACER)
nasdaq.com - July 16 at 6:57 PM
finance.yahoo.com logoHere is What Hedge Funds Think About Acer Therapeutics Inc. (ACER)
finance.yahoo.com - June 13 at 5:57 PM
msn.com logoBRIEF-Acer Therapeutics Plans Clinical Trial For Edsivo™ (Celiprolol) Following Type B FDA Meeting
msn.com - June 10 at 9:56 AM
finance.yahoo.com logoAcer Therapeutics Plans Clinical Trial for EDSIVO™ (celiprolol) Following Type B FDA Meeting
finance.yahoo.com - June 10 at 9:56 AM
finance.yahoo.com logoWhat Makes Opexa Therapeutics, Inc. (ACER) a New Buy Stock
finance.yahoo.com - June 9 at 1:12 PM
benzinga.com logoRelief Therapeutics Reports that its...
benzinga.com - June 2 at 5:36 AM
finanznachrichten.de logoRelief Therapeutics Holding AG: Relief Appoints Dr. Taneli Jouhikainen as Chief Operating Officer
finanznachrichten.de - May 28 at 7:28 AM
finance.yahoo.com logoAcer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA
finance.yahoo.com - May 25 at 11:53 AM
finance.yahoo.com logoAcer Therapeutics Reports Q1 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - May 17 at 7:26 PM
finanznachrichten.de logoRelief Therapeutics Holding AG: Relief Points to Applied Pharma Research (APR) News re: Pivotal COVID-19 Trial Initiation with Novel Nasal Spray
finanznachrichten.de - May 17 at 2:02 PM
benzinga.com logoRelief and Applied Pharma Research (APR) Sign Binding Term Sheet for Relief to Acquire All Outstanding Shares of APR
benzinga.com - May 4 at 7:10 AM
benzinga.com logoRelief Comments on Certain Statements Made by NeuroRx, Inc. in the Amended Form S-4 Filing of Big Rock Partners Acquisition Corp.
benzinga.com - April 19 at 6:23 AM
finanznachrichten.de logoRelief Therapeutics Holding AG: Relief Engages Jan-Jaap Scherpbier of Sonsbeek Pharma Consultancy B.V. as Manufacturing and Supply Chain Consultant
finanznachrichten.de - April 7 at 8:28 AM
finance.yahoo.com logoRelief Engages Jan-Jaap Scherpbier of Sonsbeek Pharma Consultancy B.V. as Manufacturing and Supply Chain Consultant
finance.yahoo.com - April 7 at 8:28 AM
finance.yahoo.com logoWho Has Been Buying Acer Therapeutics Inc. (NASDAQ:ACER) Shares?
finance.yahoo.com - March 30 at 8:02 AM
finance.yahoo.com logoAcer Therapeutics to Participate in Needham Virtual Healthcare Conference
finance.yahoo.com - March 29 at 11:59 AM
finance.yahoo.com logoNotice of Settlement of Derivative Suits
finance.yahoo.com - March 25 at 7:46 PM
msn.com logoWhy Is It Moving? Looking At Acer Therapeutics's Price Action Today
msn.com - March 22 at 11:18 AM
marketwatch.com logoAcer Therapeutics Inc. (NASDAQ: ACER) Featured in Virtual Coverage of the 33rd Annual ROTH Conference
marketwatch.com - March 16 at 11:55 PM
benzinga.com logoWhat's Happening With ACER Stock, MGM Stock, XPEV Stock?
benzinga.com - March 15 at 9:49 AM
seekingalpha.com logoRelief Therapeutics raises CHF10M capital via private placement
seekingalpha.com - March 13 at 7:14 PM
finanznachrichten.de logoRelief Therapeutics Holding AG: Relief Announces CHF 10 Million Private Placement
finanznachrichten.de - March 12 at 12:04 PM
finance.yahoo.com logoAcer Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
finance.yahoo.com - March 1 at 7:00 PM
finance.yahoo.com logoAcer Therapeutics to Participate in March Virtual Investor Conferences
finance.yahoo.com - March 1 at 8:59 AM
Get Acer Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACER and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.